{"id":8441,"date":"2019-02-19T15:54:34","date_gmt":"2019-02-19T14:54:34","guid":{"rendered":"https:\/\/junge-erwachsene-mit-krebs.de\/ueber-uns\/kuratorium\/"},"modified":"2025-04-01T17:23:02","modified_gmt":"2025-04-01T15:23:02","slug":"board-of-trustees","status":"publish","type":"page","link":"https:\/\/junge-erwachsene-mit-krebs.de\/en\/about-us\/board-of-trustees\/","title":{"rendered":"Board of trustees"},"content":{"rendered":"
\n

Prof. Dr. med. Inken Hilgendorf<\/h3> \"image
\n Information<\/summary>\n
\n
    \n
  • Chairwoman of the Board of Trustees<\/li>\n<\/ul>\n
      \n
    • Born in 1974<\/li>\n<\/ul>\n
        \n
      • Study of human medicine<\/li>\n<\/ul>\n
          \n
        • Specialist in internal medicine, hematology and oncology<\/li>\n<\/ul>\n
            \n
          • Deputy Clinic Director and Section leader for Stem Cell Transplantation at the Clinic for Internal Medicine II, Jena University Hospital<\/li>\n<\/ul>\n
              \n
            • Clinical and scientific focus: hematopoietic stem cell transplantation including immune reconstitution, pathophysiology and therapy of donor-versus-host disease (GVHD), health services research on late effects and long-term follow-up care after cancer therapy<\/li>\n<\/ul>\n
                \n
              • Member of the DGHO advisory board<\/li>\n<\/ul>\n
                  \n
                • Chairwoman of the AYA network of DGHO<\/li>\n<\/ul>\n <\/div>\n <\/details>\n <\/div>

                  Prof. Dr. med. Carl F. Classen<\/h3> \"image
                  \n Information<\/summary>\n
                  \n
                    \n
                  • Member of the Board of Trustees<\/li>\n<\/ul>\n
                      \n
                    • Born in 1962<\/li>\n<\/ul>\n
                        \n
                      • Specialist in paediatrics with continuing education in paediatric hematology and oncology<\/li>\n<\/ul>\n
                          \n
                        • Senior physician at the University Children\u2019s and Youth Hospital at the University Hospital Rostock<\/li>\n<\/ul>\n
                            \n
                          • Head of the Brain Tumor Vaccine Working Group<\/li>\n<\/ul>\n <\/div>\n <\/details>\n <\/div>

                            Prof. Dr. med. Lorenz Tr\u00fcmper<\/h3> \"image
                            \n Information<\/summary>\n
                            \n
                              \n
                            • Member of the Board of Trustees<\/li>\n
                            • Born in 1958<\/li>\n
                            • Study of human medicine, specialist in internal medicine and haemato-oncology<\/li>\n
                            • 1992 bis 2000: Senior physician, Saarland University, Internal Medicine I, Homburg\/SaarGroup Leader Lymphomas Research, Saarland University,\u00a0Dean of Studies Medical Faculty G\u00f6ttingen, Member, Steering Committee, DSHNHL Trial Group; Member,
                              \nGLSG and GHSG Trial Panels, KML Group<\/li>\n
                            • Since2001: Professor (C4) and Chairman, Georg-August-University G\u00f6ttingen, Department of Hematology and Medical Oncology<\/li>\n
                            • 2008 bis 2018: Founding director of the G\u00f6ttingen Comprehensive Cancer Center G-CCC<\/li>\n
                            • Since 2020: Executive Director of German Society for Hematology and Medical Oncology e.V. (DGHO)<\/li>\n
                            • Scientific work in the field of\u00a0Molecular mechanisms of lymphomagenesis, Mechanisms of invasion and metastasis, Clinical research in malignant lymphoma, stem cell transplantation and cellular therapy<\/li>\n<\/ul>\n <\/div>\n <\/details>\n <\/div>

                              Prof. Dr. med. Anne Letsch<\/h3> \"image
                              \n Information<\/summary>\n
                              \n
                              \n
                              \n
                                \n
                              • Member of the Board of Trustees<\/li>\n<\/ul>\n
                                \n
                                \n
                                <\/div>\n
                                <\/div>\n<\/div>\n<\/div>\n

                                 <\/p>\n<\/div>\n<\/div>\n <\/div>\n <\/details>\n <\/div>

                                Prof. Dr. med. Marie von Lilienfeld-Toal<\/h3> \"image
                                \n Information<\/summary>\n
                                \n
                                  \n
                                • Member of the Board of Trustees<\/li>\n
                                • Born in 1971<\/li>\n
                                • Specialist in internal medicine, specializing in hematology and internal oncology<\/li>\n
                                • Chair of Diversity Medicine at Ruhr University Bochum since 2023<\/li>\n
                                • Clinical and scientific focus: Health services research with an intersectional focus, multiple myeloma, infections in people with cancer, supportive therapy<\/li>\n
                                • Member of the DGHO advisory board<\/li>\n
                                • Chairwoman of the DGHO working group on diversity and individual medicine<\/li>\n<\/ul>\n <\/div>\n <\/details>\n <\/div> <\/div>\n<\/div>\n\n\n
                                  \n
                                  \n \t\t